Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia

Saudi Journal of Gastroenterology

Volumn 16, Issue 3, 2010, Pages 207-214

  Salem, Eyad M ^a   Yar, Talay ^a   Bamosa, Abdullah O ^a   Al Quorain, Abdulaziz ^a   Yasawy, Mohamed I ^a   Alsulaiman, Raed M ^a   Randhawa, Muhammad A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Amoxicillin; black seeds; clarithromycin; H. pylori; N. sativa; non ulcer dyspepsia; rapid urease test; triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GASEC; NIGELLA SATIVA EXTRACT; OMEPRAZOLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIULCER AGENT; PLANT EXTRACT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG DOSE COMPARISON; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; SAUDI ARABIA; TREATMENT OUTCOME; ADOLESCENT; ANALYSIS OF VARIANCE; BLACK CUMIN; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECTS; HELICOBACTER INFECTIONS; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PHYTOTHERAPY; PLANT SEED; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHI-SQUARE DISTRIBUTION; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NIGELLA SATIVA; OMEPRAZOLE; PHYTOTHERAPY; PLANT EXTRACTS; QUESTIONNAIRES; SEEDS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77954782431     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.65201     Document Type: Article

References (41)

1. Hocker M, Hohenberger P. Helicobacter pylori virulence factors-one part of a big picture. Lancet 2003;362:1231-1233
2. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-490
3. Parsonnet J. Helicobacter pylori: the size of the problem. Gut 1998;43:S6-9.
4. Frenck RW Jr, Clemens J. Helicobacter in the developing world. Microbes Infect 2003;5:705-713
5. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781 (Pubitemid 46854190)
6. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006;6:699-709.
7. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, Sulka A, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 2004;10:1088-1094
8. Savarino V, Zentilin P, Pivari M, Bisso G, Raffaella Mele M, Bilardi C, et al. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther 2000;14:893-900.
9. Wang WH, Wong BC, Mukhopadhyay AK, Berg DE, Cho CH, Lai KC, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther 2000;14:901-910
10. Ohno T, Kita M, Yamaoka Y, Imamura S, Yamamoto T, Mitsufuji S, et al. Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter 2003;8:207-215
11. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005;5:1749-1770
12. Khan MA. Chemical composition and medicinal properties of Nigella sativa Linn. Inflammopharmacology 1999;7:15-35.
13. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003;17:299-305.
14. Toppozada HH, Mazloum HA, el-Dakhakhny M. The antibacterial properties of the Nigella sativa l. seeds. Active principle with some clinical applications. J Egypt Med Assoc 1965;48:187S-202.
15. Hanafy MS, Hatem ME. Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J Ethnopharmacol 1991;34:275-278
16. Morsi NM. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta Microbiol Pol 2000;49:63-74.
17. O'Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol 2005;11:7499-7507
18. Akhtar MS, Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J Pak Med Assoc 1991;41:185-187
19. Bamosa AO, Ali BA, Sowayan SA. Effect of oral ingestion of Nigella sativa seeds on some blood parameters. Saudi Pharm J 1997;5:126-129
20. Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 2002;9:69-74. (Pubitemid 34184213)
21. Badary OA, Al-Shabanah OA, Nagi MN, Al-Bekairi AM, Almazar MM. Acute and subchronic toxicity of thymoquinone in mice. Drud Develop Res 1998;44:56-61.
22. Hirschl AM, Makristathis A. Methods to detect Helicobacter pylori: from culture to molecular biology. Helicobacter 2007;12:6-11.
23. Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:1921-1930
24. Fraser A, Delaney BC, Ford AC, Qume M, Moayyedi P. The Short-Form Leeds Dyspepsia Questionnaire validation study. Aliment Pharmacol Ther 2007;25:477-486
25. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection- a meta- analysis. Aliment Pharmacol Ther 1999;13:857-864
26. Ulmer HJ, Beckerling A, Gatz G. Recent use of proton pump inhibitor- based triple therapies for the eradication of H pylori: a broad data review. Helicobacter 2003;8:95-104.
27. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources ofvariation of Helicobacter pylori treatment success in adults worldwide: a meta- analysis. Int J Epidemiol 2002;31:128-139
28. Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, et al. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 1998;93:584-590
29. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-1864 (Pubitemid 23324400)
30. Higuchi K, Arakawa T, Ando K, Fujiwara Y, Uchida T, Kuroki T. Eradication of Helicobacter pylori with a Chinese herbal medicine without emergence of resistant colonies. Am J Gastroenterol 1999;94:1419-1420
31. Ndip RN, Malange Tarkang AE, Mbullah SM, Luma HN, Malongue A, Ndip LM, et al. In vitro anti-Helicobacterpylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol 2007;114:452-457
32. Zaidi SF, Yamada K, Kadowaki M, Usmanghani K, Sugiyama T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J Ethnopharmacol 2009;121:286-291
33. Galan MV, Kishan AA, Silverman AL. Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig Dis Sci 2004;49:1088-1090
34. Bigard MA, Delchier JC, Riachi G, Thibault P, Barthelemy P. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther 1998;12:383-388
35. Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P, et al. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut 2000;46:615-621
36. Al Mofleh IA, Alhaider AA, Mossa JS, Al-Sohaibani MO, Al-Yahya MA, Rafatullah S, et al. Gastroprotective effect of an aqueous suspension of black cumin Nigella sativa on necrotizing agents-induced gastric injury in experimental animals. Saudi J Gastroenterol 2008;14:128-134
37. Sikkema J, de Bont JA, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 1995;59:201-222
38. Bolling-Sternevald E, Lauritsen K, Aalykke C, Havelund T, Knudsen T, Unge P, et al. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002;37:1395-1402
39. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut 2002;50:36-41.
40. Kanter M, Demir H, Karakaya C, Ozbek H. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol 2005;11:6662-6666
41. El-Abhar HS, Abdallah DM, Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol 2003;84:251-258